Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes

Research output: Contribution to journalJournal articleResearch

  • Dominique Costagliola
  • Bruno Ledergerber
  • Carlo Torti
  • Ard van Sighem
  • Daniel Podzamczer
  • Amanda Mocroft
  • Maria Dorrucci
  • Bernard Masquelier
  • Andrea de Luca
  • Klaus Jansen
  • Stephane De Wit
  • Obel, Niels
  • Gerd Fätkenheuer
  • Giota Touloumi
  • Cristina Mussini
  • Antonella Castagna
  • Cristoph Stephan
  • Federico García
  • Robert Zangerle
  • Xavier Duval
  • Santiago Perez-Hoyos
  • Laurence Meyer
  • Jade Ghosn
  • Céline Fabre-Colin
  • Jesper Kjaer
  • Genevieve Chêne
  • Jesper Grarup
  • Andrew Phillips
  • Rebecca Lodwick
  • Carlo Torti
  • Maria Dorrucci
  • Huldrych F Günthard
  • Claudia Michalik
  • George Chrysos
  • Antonella Castagna
  • Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE)
Low CD4(+) T-cell counts are the main factor leading to clinical progression in human immunodeficiency virus type 1 (HIV-1) infection. We aimed to investigate factors affecting CD4(+) T-cell counts after triple-class virological failure.
Original languageEnglish
JournalThe Journal of Infectious Diseases
Volume207
Issue number5
Pages (from-to)759-67
Number of pages9
ISSN0022-1899
DOIs
Publication statusPublished - 1 Mar 2013

    Research areas

  • Adult, Anti-Retroviral Agents, CD4 Lymphocyte Count, Female, HIV Infections, Humans, Male, Middle Aged, Treatment Failure, Viral Load

ID: 93926381